XenoGesis is teaming up with Sygnature Discovery and DMDG to host the forthcoming meeting on predictive toxicology in Discovery DMPK.
The one-day meeting will be held at BioCity, Nottingham on Thursday 22nd March 2018.
The meeting will provide a forum for the exchange of ideas between members of the DMPK and toxicology research communities. The event will bring together talks from thought leaders in industry and academia to provide global perspectives on how predictive toxicology platforms have evolved and become key to the drug discovery and development process.
XenoGesis and Sygnature Discovery will be joined by speakers from the University of Birmingham, ApconiX, AstraZeneca, University of Swansea, Envigo and Imperial College.
Read more here: XenoGesis and Sygnature Discovery to Host DMDG Meeting: Predictive Toxicology in Discovery DMPK
